Screener
ARS Pharmaceuticals, Inc. SPRY Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026.
- Filed
- May 15, 2026, 6:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-225142
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value per share; 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value per share; 200,000,000 shares authorized at March 31, 2026 and December 31, 2025; 99,300,137 and 99,290,926 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 10 | 10 |
| Additional paid-in capital | 416,615 | 408,726 |
| Accumulated other comprehensive (loss) gain, net | (96) | 125 |
| Accumulated deficit | (355,221) | (294,603) |
| Total stockholders’ equity | 61,308 | 114,258 |
| Total liabilities and stockholders’ equity | $287,571 | $327,652 |
Item 1. Financial Statements
FAQ
- What is ARS Pharmaceuticals, Inc.'s total equity?
- ARS Pharmaceuticals, Inc. (SPRY) reported total equity of $61.31M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s total equity changed year-over-year?
- ARS Pharmaceuticals, Inc.'s total equity decreased by 73.2% year-over-year, from $228.97M to $61.31M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s total equity?
- Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s total equity has grown at a 52.1% compound annual growth rate (CAGR), from -$14.05M to $114.26M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about ARS Pharmaceuticals, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude